Spiroarborin, an ent -Clerodane Homodimer from Callicarpa arborea as an Inhibitor of the Eleven-Nineteen Leukemia (ENL) Protein by Targeting the YEATS Domain

De-Bing Pu,Si-Qi Guo,Dong-Xuan Ni,Jing Lin,Jun-Bo Gao,Xiao-Ning Li,Rui-Han Zhang,Xiao-Li Li,Cheng Luo,Shi-Jie Chen,Wei-Lie Xiao
DOI: https://doi.org/10.1021/acs.jnatprod.1c00775
IF: 5.1
2022-01-14
Journal of Natural Products
Abstract:A spiro <i>ent</i>-clerodane homodimer with a rare 6/6/6/6/6-fused pentacyclic scaffold, spiroarborin (<b>1</b>), together with four new monomeric analogues (<b>2</b>-<b>5</b>), were isolated from <i>Callicarpa arborea</i>. Their structures were elucidated by comprehensive spectroscopic data analysis, quantum-chemical calculations, and X-ray diffraction. A plausible biosynthetic pathway of <b>1</b> was proposed, and a biomimetic synthesis of its derivative was accomplished. Compound <b>1</b> showed a potent inhibitory effect by directly binding to the YEATS domain of the 11-19 leukemia (ENL) protein with an IC<sub>50</sub> value of 7.3 μM. This gave a <i>K</i><sub>D</sub> value of 5.0 μM, as recorded by a surface plasmon resonance binding assay.
plant sciences,chemistry, medicinal,pharmacology & pharmacy
What problem does this paper attempt to address?